Rs to adverse drug reactions reporting in neighborhood pharmacy settings in Dhaka, BangladeshMohammad Nurul Amin,1 Tahir Mehmood Khan,2 Syed Masudur Rahman Dewan,1 Mohammad Safiqul Islam,1 Mizanur Rahman Moghal,1 Long Chiau Ming3,To cite: Amin MN, Khan TM, Dewan SMR, OPC-8212 pubmed ID:http://www.ncbi.nlm.nih.gov/pubmed/21330118 et al. Crosssectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh. BMJ Open 2016;6:e010912. doi:10.1136bmjopen-2015010912 Prepublication history for this paper is available on the internet. To view these files please go to the journal on line (http:dx.doi.org10.1136 bmjopen-2015-010912). Received 21 December 2015 Revised 29 March 2016 Accepted 29 AprilABSTRACT Objectives: To assess community pharmacists’pharmacy technicians’ expertise and perceptions about adverse drug reactions (ADRs) and barriers towards the reporting of such reactions in Dhaka, Bangladesh. System: A cross-sectional study was planned to approach possible respondents for the study. A selfadministered questionnaire was delivered to neighborhood pharmacistspharmacy technicians (N=292) practising in Dhaka, Bangladesh. Results: The general response to the survey was 69.five (n=203). The majority of your sample was comprised of pharmacy technicians (152, 74.9 ) who possessed a diploma in pharmacy, followed by pharmacists (37, 18.2 ) and other folks (12, 5.9 ). Overall, 72 (35.5 ) of the respondents disclosed that they had knowledgeable an ADR at their pharmacy, yet more than half (105, 51.7 ) weren’t familiar with the existence of an ADR reporting physique in Bangladesh. Exploring the barriers to the reporting of ADRs, it was revealed that the leading four barriers to ADR reporting had been `I usually do not know how to report (Relative Importance Index (RII)=0.998)’, `reporting types will not be accessible (0.996)’, `I am not motivated to report (0.997)’ and `Unavailability of skilled atmosphere to go over about ADR (RII=0.939)’. Moreover to these, a majority (141, 69.46 ) were not confident about the classification of ADRs (RII=0.889) and were afraid of legal liabilities associated with reporting ADRs (RII=0.806). Furthermore, a lack of knowledge about pharmacotherapy and the detection of ADRs was an additional key factor hindering their reporting (RII=0.731). Conclusions: The Directorate of Drug Administration in Bangladesh needs to contemplate the results of this study to help it improve and simplify ADR reporting in Bangladeshi neighborhood pharmacy settings.Strengths and limitations of this studyFindings from the existing study will help policymakers to understand the challenges to adverse drug reactions (ADRs) reporting in community pharmacy settings and hence to intervene to make the ADR reporting process less difficult and much more accessible to pharmacists and pharmacy technicians practising in Bangladesh. The Directorate of Drug Administration in Bangladesh can make the ADR reporting procedure more efficient by producing the reporting types a lot easier to access. In addition, provided that unavailability of a professional atmosphere to discuss about ADR was a significant barrier identified to the reporting of ADRs, the Bangladeshi Pharmacy Association and registration councils can play a proactive role in organising frequent continuous education and training events where pharmacists get the opportunity to go over such experiences with other pharmacists. One of several prospective limitations is definitely the smaller number of pharmacists who participated in this study. Nonetheless, the whole sample was representative of Banglades.